Challenges in access to novel IgA nephropathy therapeutics in South Asia

IgA nephropathy (IgAN) is a major cause of chronic kidney disease in South Asia, particularly among young adults. Although recent therapeutic advances have transformed IgAN management globally, access to these treatments in South Asia remains limited. Most patients continue to rely on supportive car